Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine

By Uy Jonathan   Yang Rong   Wirtz Victoria   Sheppard Louise   Farajallah Awny   McGrath Donnie  

AIDS Care, Vol. 23, Iss. 11, 2011-11 ,pp. : 1500-1504

Routledge Ltd

Access to resources Recommend Favorite

Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)- Containing Regimens in Treatment-Experienced Patients with HIV

By  

Current HIV Research, Vol. 11, Iss. 4, 2013-06 ,pp. : 333-341

Bentham Science Publishers

Access to resources Recommend Favorite

Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy

By Sa-Filho D.J.   Costa L.J.   de Oliveira C.F.   Guimaraes A.P.C.   Accetturi C.V.A.   Tanuri A.   Diaz R.S.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 186-202

Elsevier

Access to resources Recommend Favorite

Fat Tissue Distribution Changes in HIV-Infected Patients Treated with Lopinavir/Ritonavir. Results of the MONARK Trial

By  

Current HIV Research, Vol. 9, Iss. 1, 2011-01 ,pp. : 31-39

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Boosted and Unboosted Atazanavir Plasma Concentration in HIV Infected Patients

By  

Current HIV Research, Vol. 11, Iss. 8, 2013-12 ,pp. : 642-646

Bentham Science Publishers

Access to resources Recommend Favorite